Brochure | April 13, 2017

IRT Expertise For A Complex Alzheimer's Study In An Academic Setting

Source: Cenduit LLC

Phase II/III Randomized, Double-Blind, Placebo-Controlled Multi-Center Study for Individuals at Risk for and with Dominantly Inherited Alzheimer’s Disease. 24 sites. 6 countries (U.S., U.K., Canada, Australia, France, Spain). 194 Randomized Patients.

access the Brochure!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)